Picture of Apogee Enterprises logo

APOG Apogee Enterprises News Story

0.000.00%
us flag iconLast trade - 00:00
Consumer CyclicalsBalancedMid CapSuper Stock

U.S. RESEARCH ROUNDUP- Constellation Brands, Northern Trust, Roper Technologies

June 27 (Reuters) - Wall Street securities analysts revised their ratings and price
targets on several U.S.-listed companies, including Constellation Brands, Northern Trust and
Roper Technologies on Tuesday. 
    
  HIGHLIGHTS        
     * Amedisys Inc  AMED.O : Credit Suisse raises target price to $101 from $100
     * Constellation Brands Inc  STZ.N : Jefferies raises target price to $300 from $293
     * Northern Trust Corp  NTRS.O : Barclays cuts target price to $94 from $107
     * Pfizer Inc  PFE.N : Jefferies cuts target price to $40 from $41
     * Roper Technologies Inc  ROP.N : Jefferies starts with buy rating; $530 target price
                
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday.
Stock entries are in alphabetical order.       
      
     * Adicet Bio Inc  ACET.O : BTIG cuts target price to $20 from $34
     * Agios Pharmaceuticals Inc  AGIO.O : RBC raises target price to $42 from $40
     * Agios Pharmaceuticals Inc  AGIO.O : SVB Securities raises target price to $46 from $34
     * Allovir Inc  ALVR.O : SVB Securities cuts target price to $15 from $18
     * Allstate Corp  ALL.N : Citigroup cuts price target to $135 from $138
     * Amedisys Inc  AMED.O : Credit Suisse raises target price to $101 from $100
     * Amedisys Inc  AMED.O : Stephens raises target price to $101 from $100
     * Amedisys Inc  AMED.O : SVB Securities raises target price to $101 from $81
     * Amyris Inc  AMRS.O : Jefferies raises target price to $0.80 from $0.65
     * Apogee Enterprises Inc  APOG.O : D.A. Davidson raises target price to $50 from $44
     * Avalo Therapeutics Inc  AVTX.O : RBC cuts target price to $0.75 from $9
     * Avalo Therapeutics Inc  AVTX.O : RBC cuts to sector perform from outperform
     * Avient Corp  AVNT.N : Jefferies cuts target price to $46 from $49
     * Cargurus Inc  CARG.O : JP Morgan initiates coverage with overweight rating; PT $29
     * Carmax Inc  KMX.N : Stephens raises target price to $78 from $60
     * Cars.com Inc  CARS.N : JP Morgan initiates coverage with overweight rating; PT $23
     * Citizens Financial  CFG.N : Barclays cuts target price to $40 from $42
     * Constellation Brands Inc  STZ.N : Jefferies raises target price to $300 from $293
     * Curo Group Holdings Corp  CURO.N : Jefferies reinstates with buy rating and $5 PT
     * Eve Holding Inc  EVEX.N : JP Morgan raises target price to $12.5 from $9
     * Fibrogen Inc  FGEN.O : Raymond James cuts to market perform from outperform
     * Fibrogen Inc  FGEN.O : Stifel cuts target price to $11 from $28
     * Fibrogen Inc  FGEN.O : Stifel cuts to hold from buy
     * Fibrogen Inc  FGEN.O : TD Cowen cuts target price to $3 from $25
     * Fifth Third Bancorp  FITB.O : Barclays cuts target price to $34 from $36
     * GMS Inc  GMS.N : Truist Securities raises target price to $72 from $60
     * Huntington Bancshares Inc  HBAN.O : Barclays cuts target price to $13 from $14
     * Keycorp  KEY.N : Barclays cuts target price to $13 from $15
     * Mercury Systems Inc  MRCY.O : Baird cuts target price to $30 from $40
     * Northern Trust Corp  NTRS.O : Barclays cuts target price to $94 from $107
     * Pfizer Inc  PFE.N : Jefferies cuts target price to $40 from $41
     * Roper Technologies Inc  ROP.N : Jefferies starts with buy rating; $530 target price
     * Staar Surgical Co  STAA.O : Jefferies cuts target price to $75 from $95
     * Truist Financial Corp  TFC.N : Barclays cuts target price to $40 from $44
     * Wolfspeed Inc  WOLF.N : Susquehanna cuts target price to $58 from $60
     * WP Carey Inc  WPC.N : JP Morgan cuts target price to $89 from $90
     * Zions Bancorporation Na  ZION.O : Barclays cuts target price to $35 from $37
 

 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))

Recent news on Apogee Enterprises

See all news